Company:  ARIAD PHARMACEUTICALS INC (ARIA)
Form Type:  10-Q
Filing Date:  5/9/2012 
CIK:  0000884731 
Address:  26 LANDSDOWNE ST 
City, State, Zip:  CAMBRIDGE, Massachusetts 02139 
Telephone:  (617) 494-0400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.12  
Change: 
-0.05 (-0.81%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.14B
Description of Business
The following Business Section contains forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain risks, uncertainties and other factors including the risk factors set forth in Part I, Item 1A of this annual report. Unless the content requires otherwise, references to �ARIAD,� �company,� �we,� �our,� and �us,� in this annual report refer to ARIAD Pharmaceuticals, Inc. and our subsidiaries. Overview ARIAD is a global oncology company whose vision is to transform the lives of cancer patients with breakthrough medicines. Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest unmet medical need � aggressive cancers where current therapies are inadequate.
Register for a Free Trial and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. UNAUDITED FINANCIAL STATEMENTS
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        STOCKHOLDERS EQUITY
      ITEM 2. MANAGEMENTS' DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1A. RISK FACTORS
      ITEM 6. EXHIBITS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 10.5
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    Certification